Vaccine against toxic shock syndrome in a first-in-man clinical trial

Expert Rev Vaccines. 2017 Feb;16(2):81-83. doi: 10.1080/14760584.2017.1268921. Epub 2016 Dec 15.

Authors

Andreas Roetzer¹, Bernd Jilma², Martha M Eibl¹

Affiliations

¹ a Biomedizinische ForschungsgmbH , Vienna , Austria.
² b Department of Clinical Pharmacology , Medical University of Vienna , Vienna , Austria.

PMID: 27918218
DOI: 10.1080/14760584.2017.1268921

No abstract available

Keywords: Staphylococcus aureus; bacterial infection; first-in-man clinical trial; toxic shock syndrome; toxoid vaccine.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Clinical Trials as Topic*
Humans
Shock, Septic / prevention & control*
Staphylococcal Infections / complications*
Staphylococcal Vaccines / administration & dosage*
Staphylococcal Vaccines / adverse effects
Staphylococcal Vaccines / immunology*
Vaccines
Vaccines, Synthetic / administration & dosage
Vaccines, Synthetic / adverse effects
Vaccines, Synthetic / immunology

Substances

Staphylococcal Vaccines
Vaccines
Vaccines, Synthetic